Connect
MJA
MJA

Pharmaceutical preparations

New Drugs, Old Drugs

Thiazolidinediones and type 2 diabetes: new drugs for an old disease

Trisha M O'Moore-Sullivan and Johannes B Prins

Med J Aust 2002; 176 (8): 381-386

Letters

"Order effect" in the provision of medication information

Abilio C de Almeida Neto, Timothy F Chen and Joyce H L Chan

Med J Aust 2002; 176 (8): 401-402

Position statement

Considerations for the safe prescribing and use of COX-2-specific inhibitors

, The Australian COX-2-Specific Inhibitor (CSI) Prescribing Group*

Med J Aust 2002; 176 (7): 328-331 Free

Letters

Pharmacological treatment of cognitive deficits in Alzheimer's disease

William Lam

Med J Aust 2002; 176 (6): 297

Letters

Pharmacological treatment of cognitive deficits in Alzheimer's disease

Henry Brodaty, Jane R Hecker, John A Snowdon and David J Ames

Med J Aust 2002; 176 (6): 297

Letters

Megadose vitamin C in treatment of the common cold: a randomised controlled trial

Carmen Audera, Roger V Patulny, Beate H Sander and Robert M Douglas

Med J Aust 2002; 176 (5): 298-299

Healthcare

Hyponatraemia and hypokalaemia due to indapamide

Michael D Chapman, Ross Hanrahan, John McEwen and John E Marley

Med J Aust 2002; 176 (5): 219-221 Free

Letters

Serotonin toxicity with therapeutic doses of dexamphetamine and venlafaxine

Felicity H Prior, Geoffrey K Isbister, Andrew H Dawson and Ian M Whyte

Med J Aust 2002; 176 (5): 240-241

Letters

Venlafaxine and bilateral acute angle closure glaucoma

Bradley Ng, G Mark C Sanbrook, Anthony J Malouf and Smita A Agarwal

Med J Aust 2002; 176 (5): 241

Letters

Mirtazapine-induced akathisia

Boregowda G Girishchandra, Liana Johnson, Rebecca M Cresp and Kenneth G D Orr

Med J Aust 2002; 176 (5): 242

Letters

Megadose vitamin C in treatment of the common cold: a randomised controlled trial

Luis Vitetta, Avni Sali, Bill Paspaliaris and Nicola J Reavley

Med J Aust 2002; 176 (5): 298-299

Medicine and the community

Paracetamol recall: a natural experiment influencing analgesic poisoning

Corrine R Balit, Geoffrey K Isbister, Andrew H Dawson, Ian M Whyte and Jennifer Peat

Med J Aust 2002; 176 (4): 162-165 Free

Letters

Epidemiological modelling (including economic modelling) and its role in preventive drug therapy

Kent R Johnson and Marissa N Lassere

Med J Aust 2002; 178 (4): 188-189

Letters

Content of isoflavone-containing preparations

Jan B Howes and Laurence G Howes

Med J Aust 2002; 176 (3): 135-136

Letters

COX-2 inhibition and thrombotic tendency

Christopher G Fenn

Med J Aust 2002; 176 (2): 88

Letters

COX-2 inhibition and thrombotic tendency

Leslie G Cleland and Michael J James

Med J Aust 2002; 176 (2): 88

Updates in medicine

Neurology and neurosurgery

Graeme J Hankey

Med J Aust 2002; 176 (1): 26

Updates in medicine

Clinical pharmacology

Gillian M Shenfield, David G Le Couteur and Laurent P Rivory

Med J Aust 2002; 176 (1): 9

Updates in medicine

Gastroenterology and hepatology

Amanda J Nicoll, Ian J Kronborg and Neville D Yeomans

Med J Aust 2002; 176 (1): 14

Notable cases

Treatment failure due to methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin

Peter B Ward, Elizabeth A Grabsch and Barrie C Mayall

Med J Aust 2001; 175 (9): 480-483 Free

Position statement

Anticoagulation in pregnancy and the puerperium

Med J Aust 2001; 175 (5): 258-263 Free

ADRAC

Bupropion-induced hypersensitivity reactions

Elizabeth Benson

Med J Aust 2001; 174 (12): 650-651

Healthcare

Poisoning with the recreational drug paramethoxyamphetamine ("death")

Colin Marchant, Nicholas A Buckley, Michael Prior and Rod J Irvine

Med J Aust 2001; 174 (9): 453-455

Christmas offerings

Would the pharmaceutical companies please mind their Ps and Qs, and their Xs, Ys and Zs

Gordon B Parker

Med J Aust 2000; 173 (11): 662-663

Research

Recent trends in the use of antidepressant drugs in Australia, 1990-1998

Peter McManus, Andrea Mant, Philip B Mitchell, William S Montgomery, John Marley and Merran E Auland

Med J Aust 2000; 173 (9): 458-461 Free